Inventor · disambiguated record
Justin W. Jackson
Also filed as: JACKSON JUSTIN W · JACKSON JUSTIN WILLIAM
11 granted patents·9 pending applications·29 citations·filing 2015–2025
86Inventor score
Files withSCHOLAR ROCK INC20
Top patents by PatentIndex Score
20 records- 0192US11925683B2Compositions for making and using anti-Myostatin antibodiesSCHOLAR ROCK INC·Filed 2021·Granted Mar 12, 2024·2 cites·9 claims
- 0291US11135291B2Methods for making and using anti-myostatin antibodiesSCHOLAR ROCK INC·Filed 2019·Granted Oct 5, 2021·10 cites·26 claims
- 0391US10307480B2Anti-pro/latent-myostatin antibodies and uses thereofSCHOLAR ROCK INC·Filed 2015·Granted Jun 4, 2019·12 cites·19 claims
- 0488US11214614B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2020·Granted Jan 4, 2022·2 cites·3 claims
- 0586US11365245B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2021·Granted Jun 21, 2022·1 cites·8 claims
- 0685US12122823B2Isoform-selective TGFB1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Granted Oct 22, 2024·1 cites·13 claims
- 0782US2025179164A1LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOFSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 0879US2024374718A1Anti-pro/latent-myostatin antibodies and uses thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 0977US11130803B2Isoform-selective TGFβ1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 1077US2025215072A1Isoform-selective tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1175US12173059B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2022·Granted Dec 24, 2024·0 cites·20 claims
- 1268US12338279B2Selective and potent inhibitory antibodies of myostatin activationSCHOLAR ROCK INC·Filed 2024·Granted Jun 24, 2025·0 cites·11 claims
- 1363US12252531B2Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitorsSCHOLAR ROCK INC·Filed 2019·Granted Mar 18, 2025·0 cites·5 claims
- 1460US2025304669A1Rgmc-selective inhibitors and use thereofSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 1558US2024301073A1LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb1 AND USES THEREOFSCHOLAR ROCK INC·Filed 2022·Application pending·0 cites
- 1658US2025257125A1HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 1756US12297262B2RGMC-selective inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted May 13, 2025·0 cites·35 claims
- 1856US2024294623A1Tgf-beta inhibitors and therapeutic use thereofSCHOLAR ROCK INC·Filed 2022·Application pending·0 cites
- 1945US2021340238A1TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 2036US2018208648A1Gdf11 binding proteins and uses thereofSCHOLAR ROCK INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Justin W. Jackson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →